
Stemline Therapeutics (STML) Earnings Dates & Reports
Stemline Therapeutics (STML) Most Recent Earnings
Report DateMar 13, 2020
Period EndingQ4 2019
Est. EPS-$0.35
Actual EPS-$0.38
EarningsMiss
Stemline Therapeutics (STML) Earnings
View the latest Stemline Therapeutics (STML) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Stemline Therapeutics (STML)
Order type
Buy in
Order amount
Est. shares
0 shares
Stemline Therapeutics (STML) Earnings per Share (EPS) History
Signup for full accessBrowse free
Stemline Therapeutics (STML) Latest Earnings
The value each STML share was expected to gain vs. the value each share gained.
Stemline Therapeutics (STML) reported its most recent earnings on Mar 13, 2020 for Q4 2019, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.35 by 8.57%, marking a Miss.
For comparison, Stemline Therapeutics reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 03/13/2020, with analysts projecting an EPS of $0.
Stemline Therapeutics (STML) Earnings History
Stemline Therapeutics (STML) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Stemline Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|
Stemline Therapeutics (STML) Earnings FAQs
Stemline Therapeutics (STML) last reported earnings on Mar 13, 2020 for Q4 2019, posting an EPS of -$0.38, which Miss the estimate of -$0.35 by 8.57%.
For Q4 2019, Stemline Therapeutics (STML) reported an EPS of -$0.38, missing analysts' estimate of -$0.35 by 8.57%.
For Q4 2019, Stemline Therapeutics (STML) Miss expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.35.
Following the last earnings report on Mar 13, 2020, Stemline Therapeutics (STML)'s stock price moved — from — to —.
The next Stemline Therapeutics (STML) earnings call is scheduled for Mar. 13, 2020, where executives will discuss financial results and outlook.